TIKVA ALLOCELL PTE. LTD.
Tikva Allocell develops off-the-shelf chimeric antigen receptor T cell therapies to treat solid tumors. The technology is based on an enhanced virus-specific T cell platform.
Operating in biotech based in Singapore, TIKVA ALLOCELL PTE. LTD. was founded in 2023.
As a business in biotech, TIKVA ALLOCELL PTE. LTD. is listed here with the public details available about it.
Singapore is where the company is located.
Its current recorded stage is Startup SG directory startup.
Its team size is recorded as 11 - 50 employees.
| Sector | Biotech |
|---|---|
| Country | Singapore |
| Founded | 2023 |
| Employees | 11 - 50 |
| Stage | Startup SG directory startup |
Website: tikvaallocell.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account